Correlation of tumor enhancement and imaging features on multiphasic multidetector CT with microvessel density as a step toward a minimally invasive method to predict Fuhrman nuclear grade in patients with clear cell renal cell carcinoma.

医学 肾透明细胞癌 放射科 逻辑回归 肾细胞癌 接收机工作特性 活检 回顾性队列研究 秩相关 核医学 病理 内科学 计算机科学 机器学习
作者
Heidi Coy,Jonathan R. Young,Michael Douek,Clara E. Magyar,Anthony Sisk,Matthew S. Brown,James Sayre,Steven S. Raman
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology]
卷期号:35 (15_suppl): e16049-e16049
标识
DOI:10.1200/jco.2017.35.15_suppl.e16049
摘要

e16049 Background: Clear cell renal cell carcinoma (ccRCC) is the most common tumor of the kidney. Up to 70% are incidentally detected on multiphasic CT. The prognosis for patients with ccRCC is related to Fuhrman grade (FG) and is diagnosed by biopsy or excision. There is a great need for a non-invasive method to assess tumor grade which may help inform clinical decision-making. The purpose of our study is to determine if contrast enhancement on CT predicts FG and microvessel density (MVD) of ccRCC lesions and to assess which combination of quantitative and qualitative radiological features and clinical features predict high FG ccRCC lesions. Methods: With IRB approval for this HIPAA-compliant retrospective study, our pathology and imaging databases were queried to obtain a cohort of ccRCC with a preoperative multiphasic (unenhanced (U), corticomedullary (C), nephrographic (N), and excretory (E)) CT scan. Tumors were stained with CD4 to quantify % MVD. Spearman’s rank correlation was calculated to test the strength of the association between CT enhancement, %MVD and FG. Stepwise logistic regression analysis was performed to determine the quantitative and/or qualitative feature with the highest performance in predicting high FG tumor. The multivariate logistic regression analysis was evaluated using ROC curves and AUCs. Results: Our cohort had 127 patients with 89 low-grade tumors and 43 high-grade tumors. The %wash-in of enhancement from the U to the C phase showed a significant correlation with %MVD of the tumor (R 2 = 0.181,p < . 001) as did enhancement of the tumor in the early C phase with %MVD (R 2 = 0.159,p < . 001). There was a significant inverse correlation with %MVD and FG (R 2 = 0.137,p < . 001). T-stage, tumor size, %MVD and presence of renal vein invasion were determined to be significant independent predictors of high grade lesions with an AUC of .838 (95% CI .748-.927). Conclusions: Lower grade ccRCC tumors have a higher MVD. Therefore, contrast material washes in at a faster rate from the UN to the CM phase, enabling low grade to be discriminated from high-grade tumors on CT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
潇洒的如松完成签到,获得积分10
刚刚
刚刚
xiuuu发布了新的文献求助10
刚刚
阳光土豆发布了新的文献求助30
1秒前
1秒前
CipherSage应助孙浩洋采纳,获得10
1秒前
aobo发布了新的文献求助10
2秒前
2秒前
直率毛豆发布了新的文献求助10
2秒前
han完成签到,获得积分10
3秒前
3秒前
Adi完成签到,获得积分10
4秒前
LSH970829发布了新的文献求助10
4秒前
5秒前
5秒前
jin发布了新的文献求助10
5秒前
6秒前
genau000完成签到 ,获得积分10
6秒前
7秒前
楠111111111发布了新的文献求助10
7秒前
dt完成签到,获得积分10
7秒前
JamesPei应助逸群采纳,获得10
8秒前
阳光土豆完成签到,获得积分10
9秒前
清爽山河完成签到 ,获得积分10
9秒前
优美的达发布了新的文献求助10
9秒前
学术嫪毐发布了新的文献求助10
10秒前
量子星尘发布了新的文献求助10
10秒前
天涯赤子发布了新的文献求助10
10秒前
10秒前
Vintor完成签到,获得积分10
10秒前
传奇3应助yang采纳,获得10
11秒前
青年才俊发布了新的文献求助10
11秒前
乌压压完成签到,获得积分20
11秒前
11秒前
12秒前
云云完成签到 ,获得积分10
12秒前
松松宝宝发布了新的文献求助10
12秒前
12秒前
sss发布了新的文献求助10
13秒前
简单白梦完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
化妆品原料学 1000
《药学类医疗服务价格项目立项指南(征求意见稿)》 1000
花の香りの秘密―遺伝子情報から機能性まで 800
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
nephSAP® Nephrology Self-Assessment Program - Hypertension The American Society of Nephrology 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5630828
求助须知:如何正确求助?哪些是违规求助? 4723716
关于积分的说明 14975757
捐赠科研通 4789049
什么是DOI,文献DOI怎么找? 2557396
邀请新用户注册赠送积分活动 1518110
关于科研通互助平台的介绍 1478700